 Telegraph.co.uk |
Experimental Asthma Drug Halves Attacks
The Inquisitr The Telegraph reports the medicine is called mepolizumab and treats a rare form of the condition in which white blood cells called eosinophils cause lung airways to become inflamed. The new asthma drug is injected, and reduces the number of eosinophils … Glaxo's Experimental Drug Halves Asthma Attacks in Study Experimental Drug May Cut Severe Asthma Attacks: Study GSK drug halves attacks in hard-to-treat asthma |
View full post on asthma – Google News